FDA Gives Nod to Start of Phase 1 Drug Trial for NTM Infections
News
Matinas BioPharma Holdings of Bedminster, N.J., recently announced that its investigational new drug (IND) application to the U.S. Food and Drug Administration is open and the company has been authorized to ... Read more